Hanson Kristopher
Insider CIK 1789970 · PHAS Vice President, Head of Legal · MPLT General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-10-15 | 2026-10-16 | 9,020 | $8.08 | $72.9K | 128,024 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-09-16 | 2026-09-18 | 16,509 | $11.67 | $192.7K | 137,044 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-09-16 | 2026-09-18 | 16,509 | $11.67 | $192.7K | 137,044 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | A Award deriv | 2026-08-17 | 2026-08-19 | 31,395 | — | $0 | 31,395 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | A Award | 2026-08-17 | 2026-08-19 | 7,730 | — | $0 | 153,553 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | A Award deriv | 2026-08-17 | 2026-08-19 | 31,395 | — | $0 | 31,395 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | A Award | 2026-08-17 | 2026-08-19 | 7,730 | — | $0 | 153,553 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-07-17 | 2026-07-17 | 1,130 | $37.90 | $42.8K | 145,823 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-07-16 | 2026-07-17 | 11 | $37.96 | $418 | 146,953 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-07-16 | 2026-07-17 | 4,776 | $36.45 | $174.1K | 150,295 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-07-16 | 2026-07-17 | 3,331 | $37.26 | $124.1K | 146,964 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-07-15 | 2026-07-17 | 10 | $37.54 | $375 | 155,071 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-07-15 | 2026-07-17 | 2,147 | $36.00 | $77.3K | 160,184 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-07-15 | 2026-07-17 | 5,103 | $36.99 | $188.8K | 155,081 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-05-11 | 2026-05-11 | 284 | $27.61 | $7.8K | 175,964 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-05-11 | 2026-05-11 | 846 | $28.70 | $24.3K | 175,118 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-05-11 | 2026-05-11 | 6,979 | $30.04 | $209.6K | 168,139 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-05-11 | 2026-05-11 | 5,808 | $30.56 | $177.5K | 162,331 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-05-04 | 2026-05-06 | 683 | $30.08 | $20.5K | 176,248 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-05-04 | 2026-05-06 | 9,030 | $27.50 | $248.3K | 181,135 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-05-04 | 2026-05-06 | 3,908 | $28.29 | $110.6K | 177,227 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-05-04 | 2026-05-06 | 296 | $29.56 | $8.7K | 176,931 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-04-16 | 2026-04-17 | 225 | $27.49 | $6.2K | 190,165 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-04-16 | 2026-04-17 | 73 | $27.01 | $2.0K | 190,390 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | S Sale | 2026-04-15 | 2026-04-17 | 1,529 | $26.80 | $41.0K | 190,463 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | A Award deriv | 2026-02-05 | 2026-02-09 | 31,395 | — | $0 | 31,395 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | A Award | 2026-02-05 | 2026-02-09 | 7,730 | — | $0 | 191,582 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | F Tax w/h | 2026-01-27 | 2026-01-29 | 26,007 | $17.98 | $467.6K | 183,852 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | A Award deriv | 2025-10-27 | 2025-10-28 | 110,046 | — | $0 | 110,046 | SEC↗ |
| MPLT MapLight Therapeutics, Inc | A Award | 2025-10-27 | 2025-10-28 | 27,098 | — | $0 | 27,098 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award | 2022-05-20 | 2022-05-24 | 4,831 | $0.68 | $3.3K | 8,463 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-02-24 | 2022-02-28 | 18,750 | — | $0 | 18,750 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-02-24 | 2022-02-28 | 87,500 | — | $0 | 87,500 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award | 2021-11-19 | 2021-11-23 | 1,545 | $2.01 | $3.1K | 3,632 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award | 2021-05-20 | 2021-05-24 | 1,088 | $2.80 | $3.0K | 2,087 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2021-02-05 | 2021-02-09 | 36,000 | — | $0 | 36,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award | 2020-11-20 | 2020-11-23 | 999 | $3.00 | $3.0K | 999 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2020-02-12 | 2020-02-14 | 55,000 | — | $0 | 55,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2019-10-07 | 2019-10-07 | 66,000 | — | $0 | 66,000 | SEC↗ |